SIS-102-ACH

N/A

Report date: 2023/10/23 16:02:24
NME

Base Information

Drug NameSIS-102-ACH
Drug Alias NameSIS-102-ACH
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionFibroblast growth factor receptor 3 inhibitorsRNA interference
TargetsFibroblast growth factor receptor 3
Therapy Area/IndicationsAchondroplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSiSaf Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSiSaf Ltd
Inactive CompaniesN/A
Active IndicationsAchondroplasia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A